Some insights into previous outbreaks of human coronaviruses may be useful in explaining the comparatively ‘low’ numbers of COVID-19 infections and mortality in people with HIV in South Africa.
Malaria, tuberculosis and HIV/AIDS are regarded as the ‘big three’ infectious diseases. This is where scientists are at in their efforts to find a vaccine for each one.
Underlying social and structural causes of behaviour - such as poverty and gender disparities - are often ignored. But these are potential drivers of HIV infection among young people.
Nesri Padayatchi, Centre for the AIDS Program of Research in South Africa (CAPRISA) and Kogie Naidoo, Centre for the AIDS Program of Research in South Africa (CAPRISA)
The redirection of resources to COVID-19 has enormous consequences for the provision of healthcare services for other diseases, in particular, HIV programmes.
Proposals in NSW to force someone who spits at or bites a frontline worker to be tested for HIV and other blood-borne viruses are a real problem - for workers and the public.
HIV activists in South Africa laid the foundation for relatively widespread citizen trust in science and expertise. Now government must capitalise on this and drive COVID-19 prevention campaigns.
South Africa should base its COVID-19 mitigation strategy on the premise that the pandemic will last for two years unless a vaccine is developed before then.
Her commitment to the communities she was serving was unwavering. She ensured that research results were disseminated to communities before presenting at conferences.
Today is World TB Day. With attention turned toward coronavirus, it might seem too much to think about. But there’s a lot to consider about the role of young people in stopping both diseases.
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand